https://www.enterair.pl/slot-gacor/

FIRST TIME EXPERIENCE OF APPLICATION OF IMMUNE HISTOCHEMICAL TESTS OF THE RETROPERITONEAL TISSUE IN THE EARLY PHASE OF ACUTE NECROTIZING PANCREATITIS

Keywords: acute necrotizing pancreatitis, cytokines, retroperitoneal tissue, immune histochemical tests

Abstract


Background. Treatment of patients with acute necrotizing pancreatitis (SNP) against the background of an evergrowing incidence and stably high mortality in severe forms of the disease has remained an unresolved task in urgent abdominal surgery.
Objective - to identify the capabilities of immune histochemical tests in the study of early morphological changes in retroperitoneal tissue of patients with acute necrotizing pancreatitis.
Materials and methods. The article presents the results of immune histochemical studies of retroperitoneal tissue biopsy samples of patients with acute necrotizing pancreatitis, taken in the early phase of the disease (within first 72 hours), with antibodies to CD 34, Cyclooxygenase 2 (COX2), C1q Complement (С1q), C3c Complement (C3c), Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM), Interleukin 18 (IL 18), Fibrinogen, Transforming growth factor beta 1 (TGF-β 1), Vascular Endothelial Growth Factor (VEGF).
Results. It has been proved that in case of acute pancreatitis development in retroperitoneal space tissues, one can observe the activation of cyclooxygenase 2, accumulation of exudate that contains the components of C1q and C3c complements, as well as A, G and M immunoglobulins, proinflammatory cytokine interleukin 18, fibrinogen, and also growth factors – TGF-β 1 and VEGF.
Conclusion. The obtained results indicate that in acute pancreatitis, immune histochemical methods can be successfully used to detect immune and inflammatory biomarkers.

References


1. Tolstoj AD, Panov VP, Krasnorogov VB, Vashetko RV, Skorodumov AV. Parapankreatit. Jetiologija, patogenez, diagnostika, lechenie. St. Petersburg: Jasnyj svet; 2003. 256 p. (Russian).


2. Shoroh GP, Shoroh SG. Ostryj destruktivnyj pankreatit [Acute destructive pancreatitis]. Minsk: Paradoks; 2013. 208 p. (Russian).


3. Lyzikov AN, Mayorov VM, Dundarov ZA, Avizhets YuN. Morfologicheskie osobennosti jekstrapankreaticheskogo porazhenija vnutrennih organov pri ostrom fermentativnom parapankreatite [Morphological features of extrapancreatic lesion of internal organs in acute enzymatic parapancreatitis]. Problemy zdorovja i jekologii [Problems of health and ecology]. 2014;40(2):61-66. (Russian).


4. Darvin VV, Onishchenko SV, Ilkanich AIa, Amiragian DS, Shirinskiĭ VG. Miniinvazivnye tehnologii v lechenii ostrogo pankreatita [Mini-invasive technologies for the acute pancreatitis treatment]. Hirurgija. Zhurnal imeni NI Pirogova [Journal Surgery named after NI Pirogov]. 2009;1:29-32. (Russian).


5. Belorusets VN, Karpitskij AS, Golubeva NN. Morfologicheskie izmenenija v zabrjushinnoj kletchatke v rannej faze ostrogo nekrotizirujushhego pankreatita [Morphological changes in the retroperitoneal fat tissue in the early phase of acute necrotizing pancreatitis]. Novosti hirurgii [Surgery News]. 2018;26(1):34-41. (Russian).


6. Nandy D, Mukhopadhyay D. Growth factor mediated signaling in pancreatic pathogenesis. Cancers. 2011;3(1):841-871. doi: 10.3390/cancers3010841.


7. Zagorodskikh EB, Cherkasov VA, Schekotova AP. Мarkery endotelialnoj disfunkcii i ih prognosticheskoe znachenie pri ostrom pankreatite tyazhelogo techeniya [Markers of endothelial dysfunction and their prognostic value in severe acute pancreatitis]. Fundamentalnye issledovanija [Fundamental research]. 2013;9-3:355-361. (Russian).


8. Klimenko MV. Osobennosti citokinovoj reaktivnosti pri ostrom i hronicheskom pankreatite [Features of cytokine reactivity in acute and chronic pancreatitis]. Ukrainskij zhurnal hirurgii [Ukrainian journal of surgery]. 2013;2(21):111-114. (Russian).


9. Veligotskiy NN, Klimenko MV, Arutyunov SE. Rol transformiruyushego faktora rosta v opredelenii tyazhesti ostrogo pankreatita [Role of transforming growth factor in determining the severity of acute pancreatitis]. Suchasni medychni tehnologii [Modern Medical Technology]. 2012;4(16):53-56. (Russian).


10. Warzecha Z, Dembiński A, Ceranowicz P, Dembiński M, Kownacki P, Konturek SJ, Tomaszewska R, Stachura J, Hładki W, Pawlik WW. Immunohistochemical expression of FGF-2, PDGF-A, VEGF and TGF beta RII in the pancreas in the course of ischemia/reperfusion-induced acute pancreatitis. Journal of Physiology and Pharmacology. 2004;55(4):791-810.


11. Frossard JL, Hadengue A, Pastor CM. New Serum Markers for the Detection of Severe Acute Pancreatitis in Humans. American Journal of Respiratory and Critical Care Medicine. 2001;164(1):162-170. doi: 10.1164/ajrccm.164.1.2008026.


12. Ketlinskij SA, Simbircev AS. Citokiny [Cytokines]. St. Petersburg: Foliant; 2008. 552 р. (Russian).


13. Manohar M, Verma AK, Venkateshaiah SU, Sanders NL, Mishra A. Pathogenic mechanisms of pancreatitis. World Journal of Gastrointestinal Pharmacology and Therapeutics. 2017;8(1):10-25.


14. Roxvall LI, Bengtson LA, Heideman JM. Anaphylatoxins and terminal complement complexes in pancreatitis. Evidence of complement activation in plasma and ascites fluid of patients with acute pancreatitis. Archives of Surgery. 1990;125(7):918-921. doi:10.1001/archsurg.1990.01410190116019.


15. Bettac L, Denk S, Seufferlein T, Huber-Lang M. Complement in Pancreatic Disease – Perpetrator or Savior? Frontiers in Immunology. 2017;8:15. doi: 10.3389/fimmu.2017.00015.


16. Parfenov IP, Belousov VA, Yarosh AL, Karpachev AA, Soloshenko AV. Sovremennye predstavlenija o roli citokinov v patogeneze ostrogo pankreatita [The contemporary view on cytokines role in the pathogenesis of acute pancreatitis]. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. Serija, Medicina. Farmacija [Belgorod State University Scientific Bulletin. Medicine. Pharmacy]. 2011;16(111):40-45. (Russian).


17. Ueda T, Takeyama Y, Yasuda T, Matsumura N, Sawa H, Nakajima T, Ajiki T, Fujino Y, Suzuki Y, Kuroda Y. Significant elevation of serum interleukin-18 levels in patients with acute pancreatitis. Journal of Gastroenterology. 2006;41(2):158-165. doi: 10.1007/s00535-005-1735-4.


18. Nielsen JS, McNagny KM. Novel functions of the CD34 family. Journal of Cell Science. 2008;121(Pt 22):3683-3692. doi: 10.1242/jcs.037507.


19. de Almeida JLJ, Jukemura J, Coelho AMM, Patzina RA, Machado MCC, da Cunha JEM. Inhibition of cyclooxygenase-2 in experimental severe acute pancreatitis. Clinics. 2006;61(4):301-306.

Published
2019-12-18
How to Cite
1.
Belorusets VN, Karpitski AS, LetkovskayaТA. FIRST TIME EXPERIENCE OF APPLICATION OF IMMUNE HISTOCHEMICAL TESTS OF THE RETROPERITONEAL TISSUE IN THE EARLY PHASE OF ACUTE NECROTIZING PANCREATITIS. journalHandG [Internet]. 2019Dec.18 [cited 2024Jul.3];3(2):197-05. Available from: http://hepatogastro.grsmu.by/index.php/journalHandG/article/view/123
Section
Оригинальные исследования
slot gacor gampang menanghttps://moodle.educarex.es/iesjgarciatellez/forum/https://frodo.iztacala.unam.mx/uapas/https://lms-hcmv.auf.org/mod/questionnaire/images/tips-and-trick/https://cec.uisrael.edu.ec/auth/cas/new/https://csirt.rri.go.id/storage/slotonline/https://csirt.rri.go.id/js/https://diskominfo.wonosobokab.go.id/limitless/https://serasi-pnbpminerba.esdm.go.id/slot-pulsa/https://serasi-pnbpminerba.esdm.go.id/js/